Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 7-11, January 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suleiman, S. A.
Right arrow Articles by Vestling, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suleiman, S. A.
Right arrow Articles by Vestling, C. S.

Comparative Study of Mitochondrial Malate Dehydrogenase from Normal Rat Liver and Morris Hepatomas in Vivo and in Culture1

Suleiman A. Suleiman, Michael J. Niehaus, Graham L. Jones2 and Carl S. Vestling

Department of Biochemistry, The University of Iowa, Iowa City, Iowa 52242

Mitochondrial malate dehydrogenase [L-malate, nicotin-amide adenine dinucleotide oxidoreductase (EC 1.1.1.37)] from Morris rat hepatomas grown in vivo and from Morris rat hepatoma 7288C grown in cell culture (hepatic tumor cells) has been maximally purified for comparison with mitochondrial malate dehydrogenase from normal rat liver. A rabbit antiserum directed against normal rat liver mitochondrial malate dehydrogenase has been used for immunochemical characterization. Other studies included comparing rates of inactivation by proteolytic enzymes, behavior on polyacrylamide gel, and profiles of isoelectric focusing. By the criteria used, the comparisons revealed enzyme identity. The only difference is in the initial extractable total activity of the enzyme (IU/g tissue) which is lower in hepatomas.

1 Supported by a research grant from the National Cancer Institute, NIH (CA 07617).

2 Present address: Department of Human Biology, John Curtin School of Medical Research, P. O. Box 334, Canberra City, A.C.T. 2601, Australia.

Received 8/11/80. Accepted 9/18/80.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.